FDA Accepts BLA for Dr. Reddy’s Rituximab Biosimilar for Review | Goodwin – JDSupra

On July 12, Dr. Reddy’s Laboratories Ltd. (Dr. Reddy’s) announced that the U.S. Food and Drug Administration (FDA) accepted for review its …